COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?

Pugazhenthan Thangaraju¹, Meenalotchini P Gurunthalingam¹, Shobanbabu Varthya², Sajitha Venkatesan³, Eswaran Thangaraju^4
1 Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
² Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
³ Department of Microbiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
⁴ Associate Professor, Department of EEE, AKT Memeorial College of Engineering and Technology, Kallakurichi, Tamil Nadu, India

Correspondence Address:
Dr. Pugazhenthan Thangaraju
Assistant professor, Department of Pharmacology, All India Institute of Medical Sciences, Raipur - 492 099, Chhattisgarh
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/jfmpc.jfmpc_422_20